Skip to main content
Premium Trial:

Request an Annual Quote

Aventis Subscribes to Gene Logic Custom Database

NEW YORK, Dec. 13 – Aventis has subscribed to a selection of samples in Gene Logic’s database, Gene Logic said Thursday.

Under the terms of the deal, Aventis will have access to samples culled from Gene Logic’s BioExpress database. The BioExpress database contains gene expression information for normal and diseased human tissues, tissues from model animal systems, and human and animal cell lines for use in drug target identification.

Gene Logic said the deal for its CustomSuite, a customized database product, would give Aventis data directly applicable to the pharmaceutical company’s drug development projects.

In addition, Gene Logic will generate data for Aventis based on samples it provides to Gene Logic.

Gene Logic did not disclose the financial terms of the deal, its first with Aventis.

Aventis Pharmaceuticals is the U.S. division of Aventis Pharma of Frankfurt.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.